SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-006938
Filing Date
2022-06-27
Accepted
2022-06-27 16:30:15
Documents
1
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 form4-06272022_040601.html 4  
1 form4-06272022_040601.xml 4 4383
  Complete submission text file 0001415889-22-006938.txt   5836
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 42 WHITE STREET, FOURTH FLOOR NEW YORK NY 10013
Business Address
SCHAFER CAROL (Reporting) CIK: 0001272181 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 221044959